According to Sanner, the new 18,000 m² facility Kunshan II will boost production capacity by 80% which enables the company to meet demand across the region for Sanner’s pharmaceutical and medical technology products.

Ralf Tiemann, Sanner CEO Asia-Pacific, said: “The new facility marks an important milestone in the successful 23-year history of Sanner China and will substantially enhance our offering to customers in this vital region. With Kunshan II onstream we’ll be able to reliably meet growing demand, providing all our customers with products of outstanding quality backed by exceptional service.”

The construction and commissioning of Kunshan II is just one element of the company’s growth plans, said Sanner, which will include developments in Asia Pacific in addition to expansion in Germany. A new production facility and headquarters planned for the company’s Bensheim site is scheduled to come onstream in September 2024, to more than double current production capacity in Germany.